Dr. Jeffrey J. Tomaszewski, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 311
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Jefferson Medical College of Thomas Jefferson University
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
PA license MD436629 -
Student in an Organized Health Care Education/Training Program
PA license MT188674 -
Surgery Physician
PA license MD436629
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cooper University Hospital Camden, NJ
- West Jersey Hospital Voorhees, NJ
Medical groups
- Cooper Surgical Associates, PA (305 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 311
- Services billed
- 749
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 190 | 157 |
| Diagnostic exam of bladder and urethra using an endoscope | 113 | 78 |
| Established patient office or other outpatient visit, 20-29 minutes | 90 | 81 |
| Established patient office or other outpatient visit, 40-54 minutes | 79 | 72 |
| Imaging of urinary tract following injection of a contrast agent | 37 | 24 |
| Instillation of anti-cancer drug into bladder | 30 | 11 |
| New patient office or other outpatient visit, 45-59 minutes | 24 | 24 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | 19 |
| Biopsy of prostate gland | 18 | 18 |
| Ultrasound scan of pelvic region through rectum | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Camden, NJ | 221 |
| Oxybutynin Chloride Other prescribers in Camden, NJ | 75 |
| Finasteride Other prescribers in Camden, NJ | 64 |
| Myrbetriq (mirabegron) Other prescribers in Camden, NJ | 51 |
| Solifenacin Succinate Other prescribers in Camden, NJ | 40 |
| Oxycodone Hcl Other prescribers in Camden, NJ | 25 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Camden, NJ | 22 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Camden, NJ | 19 |
| Ciprofloxacin Hcl Other prescribers in Camden, NJ | 14 |
| Insulin Syringe (syringe and needle,insulin,1ml) Other prescribers in Camden, NJ | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 18 payments worth $1,021 in total to this clinician.
| Boston Scientific Corporation | $471 |
|---|---|
| Calyxo, Inc. | $145 |
| Coloplast Corp | $144 |
| Dentsply Ih Ab | $140 |
| Medtronic, Inc. | $40.00 |
| Teleflex LLC | $26.56 |
| Intuitive Surgical, Inc. | $18.87 |
| 180 Medical, Inc. | $18.54 |
| Food and Beverage | $1,021 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $222,964 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.